Publications
- The synergistic effects of DNA-damaging drugs cisplatin and etoposide with a histone deacetylase inhibitor valproate in high-risk neuroblastoma cells2015 | Faculty of Science, Second Faculty of Medicine
- Changes in MYCN expression in human neuroblastoma cell lines following cisplatin treatment may not be related to MYCN copy numbers2013 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Mechanisms of ellipticine-mediated resistance in UKF-NB-4 neuroblastoma cells2012 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells2012 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells2012 | Second Faculty of Medicine
- Mechanisms of ellipticine-mediated resistance in UKF-NB-4 neuroblastoma cells2012 | Second Faculty of Medicine
- Multilayered Polyurethane/Poly(vinyl alcohol) Nanofibrous Mats for Local Topotecan Delivery as a Potential Retinoblastoma Treatment2023 | Faculty of Science, Second Faculty of Medicine
- Apoferritin/vandetanib association is long-term stable but does not improve pharmacological properties of vandetanib2021 | Faculty of Science, Second Faculty of Medicine
- Miat is an upstream regulator of nmyc and the disruption of the miat/nmyc axis induces cell death in nmyc amplified neuroblastoma cell lines2021 | Second Faculty of Medicine
- Hydrogel implants for transscleral diffusion delivery of topotecan: In vivo proof of concept in a rabbit eye model2021 | Second Faculty of Medicine
Loading network view...